Skip to main content

Table 1 Total lipid and fatty acid composition of developing fruiting body of psyllium

From:Metabolic profiling and scavenging activities of developing circumscissile fruit of psyllium (Plantago ovataForssk.) reveal variation in primary and secondary metabolites

Fatty acids Name of fatty acids 0 day
(Stage I)
4th day
(Stage II)
8th day
(Stage III)
12th day
(Stage IV)
16th day
(Stage IV)
20th day
(Stage V)
Lipid composition
 ∑ SFA 49.71 ± 1.46 30.12 ± 1.98 25.66 ± 0.45 28.43 ± 0.65 31.14 ± 1.25 33.65 ± 2.86
 ∑ MUFA 2.31 ± 0.72 1.96 ± 0.01 1.84 ± 0.01 1.73 ± 0.08 2.07 ± 0.13 3.16 ± 0.93
 ∑ PUFA 47.98 ± 0.74 67.92 ± 1.99 72.51 ± 0.44 69.84 ± 0.73 66.79 ± 1.38 63.18 ± 3.80
 ∑ 18 PUFA 47.61 ± 0.75 66.78 ± 2.20 70.61 ± 0.81 68.19 ± 0.85 65.4 ± 1.85 61.48 ± 4.96
 ∑ 20 PUFA 0.37 ± 0.01 1.14 ± 0.21 1.90 ± 0.37 1.64 ± 0.13 1.39 ± 0.46 1.70 ± 1.17
 UI 119.25 ± 0.51 174.56 ± 3.91 188.25 ± 0.91 180.57 ± 0.09 171.52 ± 3.75 153.78 ± 8.15
 DU 98.26 ± 2.21 137.8 ± 3.97 146.85 ± 0.88 141.41 ± 1.38 135.64 ± 2.63 129.53 ± 6.66
 n6/n3 1.3 ± 0.24 1.10 ± 0.05 1.01 ± 0.01 1.00 ± 0.09 1.05 ± 0.06 2.10 ± 0.17
 n9/n3 0.11 ± 0.04 0.06 ± 0.01 0.05 ± 0.01 0.04 ± 0.01 0.06 ± 0.01 0.14 ± 0.06
 n9/n6 0.08 ± 0.02 0.06 ± 0.01 0.05 ± 0.01 0.04 ± 0.01 0.05 ± 0.01 0.06 ± 0.03
 AI 31.29 ± 3.11 38.72 ± 0.39 39.72 ± 0.79 38.14 ± 0.54 38.86 ± 0.77 48.01 ± 0.93
 TI 97.73 ± 4.25 120.52 ± 0.48 129.41 ± 0.67 128.12 ± 3.31 122.46 ± 2.25 87.19 ± 4.95
Fatty acids composition
 C12:0 Lauric acid n.d n.d n.d n.d 0.77 ± 0.59 0.63 ± 0.21
 C14:0 Myristic acid 0.27 ± 0.01 0.17 ± 0.02 0.16 ± 0.02 0.24 ± 0.01 0.29 ± 0.01 n.d
 C14:1 Myristoleic acid n.d n.d n.d n.d n.d 0.14 ± 0.02
 C15:0 Pentadecanoic acid 0.20 ± 0.01 0.18 ± 0.01 0.2 ± 0.02 0.23 ± 0.01 0.26 ± 0.01 0.22 ± 0.02
 C16:0 Palmitic acid 32.53 ± 0.73 22.61 ± 0.39 20.23 ± 0.28 21.96 ± 0.11 23.68 ± 0.97 24.53 ± 0.46
 C16:1 (n-7) Palmitoleic acid n.d n.d 0.19 ± 0.01 0.18 ± 0.02 0.24 ± 0.01 0.27 ± 0.02
 C17:0 Heptadecanoic acid 0.18 ± 0.01 0.16 ± 0.01 0.18 ± 0.01 0.20 ± 0.02 0.25 ± 0.01 0.23 ± 0.01
 C17:1 (n-7) Cis-10-Heptadecanoic acid n.d n.d n.d n.d n.d 0.06 ± 0.02
 C18:0 Stearic acid 15.31 ± 0.91 5.37 ± 1.62 3.41 ± 0.61 4.15 ± 0.55 4.44 ± 0.60 6.55 ± 2.48
 C18:1 (n-9) Oleic acid 2.14 ± 0.72 1.47 ± 0.07 1.41 ± 0.05 1.34 ± 0.10 1.65 ± 0.13 2.65 ± 0.97
 C18:2 (n-6) Linoleic acid 26.88 ± 2.46 30.66 ± 2.02 30.82 ± 0.44 30.38 ± 2.00 30.66 ± 0.30 38.84 ± 2.31
 C18:3 (n-6) gamma-Linolenic acid 20.73 ± 1.16 4.58 ± 0.19 4.72 ± 0.21 3.80 ± 0.01 3.16 ± 0.31 2.16 ± 0.43
 C18:3 (n-3) alpha-Linolenic acid [ALA] n.d 31.54 ± 0.48 35.07 ± 0.69 34.02 ± 1.03 31.57 ± 1.97 20.49 ± 2.11
 C20:0 Arachidic acid 0.67 ± 0.04 0.76 ± 0.03 0.71 ± 0.01 0.74 ± 0.06 0.70±0.06 0.52 ± 0.01
 C20:1 (n-9) Cis-11-Eicosenoic acid 0.17 ± 0.01 0.50 ± 0.06 0.23 ± 0.04 0.21 ± 0.01 0.19 ± 0.01 0.04 ± 0.01
 C20:2 Cis-11,14-Eicosadienoic acid 0.11 ± 0.02 0.51 ± 0.03 0.28 ± 0.03 0.30 ± 0.01 0.25 ± 0.04 0.10 ± 0.01
 C20:3 (n-6) Cis-8,11,14-Eicosatrienoic acid n.d n.d 0.74 ± 0.42 0.47 ± 0.22 0.29 ± 0.37 1.61 ± 1.01
 C20:3 (n-3) Cis-11,14,17-Eicosadienoic acid 0.26 ± 0.16 0.63 ± 0.06 0.87 ± 0.01 0.87 ± 0.01 0.85 ± 0.12 n.d
 C21:0 Heneicosanoic acid n.d n.d n.d 0.05 ± 0.01 0.04 ± 0.02 0.05 ± 0.01
 C22:0 Behenic acid 0.33±0.01 0.52 ± 0.05 0.43 ± 0.02 0.42 ± 0.05 0.38 ± 0.05 0.27 ± 0.02
 C23:0 Tricosanoic acid n.d n.d n.d 0.10 ± 0.01 n.d 0.07 ± 0.01
 C24:0 Lignoceric acid 0.23 ± 0.01 0.35 ± 0.06 0.32 ± 0.02 0.34 ± 0.03 0.31 ± 0.05 0.18 ± 0.02
  1. Value(%) in mean ± SE; SFA: saturated fatty acids; MUFA: mono unsaturated fatty acids; PUFA: poly unsaturated fatty acids; UI: unsaturation index; DU: degree of unsaturation; AI: Atherogenic index; TI: Thrombogenic index nd: not detected; All experiments were carried out three times, each with three biological replicates